Clinical Alpha

Clinical Alpha transforms complex biotech data into actionable insights for retail traders. Key features: • Instant analysis of clinical trials and press releases • Summaries and sentiment scores for scientific data • Real-time alerts for critical catalyst events • Cash runway analysis and burn rate scenarios Clinical Alpha decodes the jargon-filled world of biotech investing, providing clear, digestible information that previously required hours of expert analysis. By processing SEC filings, clinical trial protocols, and earnings transcripts instantly, it generates comprehensive due-diligence reports. This allows investors to quickly grasp the implications of new data, understand company health, and identify market-moving events. The platform integrates data from sources like SEC EDGAR, ClinicalTrials.gov, and NASDAQ to offer a unified view. It provides forward-looking impact scoring for upcoming events and tracks insider activity in real-time. This comprehensive market intelligence equips traders with the ability to make data-driven investment decisions, moving beyond guesswork based on complex scientific publications. Ideal for retail investors and traders focused on the biotech sector who need a competitive edge without a team of analysts. Clinical Alpha helps users identify opportunities, manage risk, and stay ahead of the market by providing institutional-grade research tools in an accessible format.